ISIS-GCCRRx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-GCCRRx, covering 2015-05-13 to 2015-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes [Phase 2]